Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Two Dosage Levels of OP2000 (75 Mg and 125 Mg) Administered Once Daily by Subcutaneous Injection for the Treatment of Active Ulcerative Colitis

NCT00033943 is registered in ClinicalTrials.gov with Incara Pharmaceuticals as lead sponsor.

NCT NCT00033943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00033943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Two Dosage Levels of OP2000 (75 Mg and 125 Mg) Administered Once Daily by Subcutaneous Injection for the Treatment of Active Ulcerative Colitis
Lead sponsor
Incara Pharmaceuticals
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2001
Completion date
September 30, 2002
Enrollment
270
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis